Literature DB >> 8397226

Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.

H Kawaguchi1, T Miyashita, H Herbst, G Niedobitek, M Asada, M Tsuchida, R Hanada, A Kinoshita, M Sakurai, N Kobayashi.   

Abstract

The clonal composition of EBV-infected cells was examined in three cases of EBV-associated hemophagocytic syndrome by analysis of the heterogeneity of terminal repetitive sequences in the EBV genome, indicating monoclonal expansion of EBV-infected cells in all cases. Involvement of T lymphoid cells was determined by in situ hybridization using 35S-labeled RNA probes specific for the small EBV-encoded nuclear RNAs, EBER1 and EBER2, in combination with immunostaining for the TCR-beta chain, CD45RO, CD20, CD30 and CD68 antigens in these three cases. The majority of lymphoid cells showing EBER transcripts were stained by antibodies against CD45RO and T cell receptor-beta. In contrast, EBER-specific signals were not detectable on B cells or hemophagocytic cells. These data support the concept that EBV-associated T cell proliferation is a primary feature of EBV-AHS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397226      PMCID: PMC288289          DOI: 10.1172/JCI116721

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.

Authors:  M Rowe; H S Evans; L S Young; K Hennessy; E Kieff; A B Rickinson
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

2.  Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex.

Authors:  A J Furley; S Mizutani; K Weilbaecher; H S Dhaliwal; A M Ford; L C Chan; H V Molgaard; B Toyonaga; T Mak; P van den Elsen
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

3.  Selectively increased production of interferon-gamma by subsets of Lyt-2+ and L3T4+ T cells identified by expression of Pgp-1.

Authors:  R C Budd; J C Cerottini; H R MacDonald
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

4.  Genetic polymorphism and exon changes of the constant regions of the human T-cell rearranging gene gamma.

Authors:  M P Lefranc; A Forster; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies.

Authors:  H Stein; K Gatter; H Asbahr; D Y Mason
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

6.  In vitro transcription of two Epstein-Barr virus specified small RNA molecules.

Authors:  P Jat; J R Arrand
Journal:  Nucleic Acids Res       Date:  1982-06-11       Impact factor: 16.971

7.  Virus associated hemophagocytic syndrome.

Authors:  R W McKenna; R J Risdall; R D Brunning
Journal:  Hum Pathol       Date:  1981-05       Impact factor: 3.466

8.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.

Authors:  N Raab-Traub; K Flynn
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

9.  T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

Authors:  J F Jones; S Shurin; C Abramowsky; R R Tubbs; C G Sciotto; R Wahl; J Sands; D Gottman; B Z Katz; J Sklar
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

10.  Clinical and laboratory evaluation of infants and children with Epstein-Barr virus-induced infectious mononucleosis: report of 32 patients (aged 10-48 months).

Authors:  C A Horwitz; W Henle; G Henle; M Goldfarb; P Kubic; R C Gehrz; H H Balfour; G R Fleisher; W Krivit
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

View more
  34 in total

1.  Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status.

Authors:  C S Verbeke; U Wenthe; W F Bergler; H Zentgraf
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

3.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

Authors:  J D Lay; C J Tsao; J Y Chen; M E Kadin; I J Su
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 4.  Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature.

Authors:  Hong-Lin He; Ming-Chung Wang; Wan-Ting Huang
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

5.  Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.

Authors:  Ming-Tsan Lin; Hui-Mei Chang; Chang-Jen Huang; Woan-Ling Chen; Chi-Yung Lin; Ching-Yang Lin; Shih-Sung Chuang
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

6.  Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease.

Authors:  Sanjaya K Satapathy; M Isabel Fiel; Juan Del Rio Martin; Costica Aloman; Thomas D Schiano
Journal:  Hepatol Int       Date:  2010-10-24       Impact factor: 6.047

7.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

8.  Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.

Authors:  Jin-Seok Lee; Jin-Han Kang; Geon-Kook Lee; Hyeon-Jin Park
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge.

Authors:  Nada Jabado; Christine McCusker; Genevieve de Saint Basile
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

10.  Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.

Authors:  Ken H Young; Dahua Zhang; Jeffery T Malik; Eliot C Williams
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.